Drugs / ENDOTHELIN

Trials 4 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT05653973 Jan 2023 → Mar 2027 expected preeclampsia Anna Stanhewicz, PhD Recruiting No outcome recorded
Phase 21 trial
Phase 2 NCT00406731 Jan 2008 → Nov 2014 Medical University of Vienna Withdrawn No outcome recorded
Phase not applicable2 trials
NCT02906085 Oct 2016 → May 2018 migraine with aura Glostrup University Hospital, Copenhagen Unknown No outcome recorded
NCT00745693 Mar → May 2008 coronary artery disorder University of Edinburgh Completed No outcome recorded

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as ENDOTHELIN ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Known as American Peptides - 88-1-10 (ET-1) American Peptides - 88-1-10 (ET-1)NCT00745693
Known as Endothelin (porcine) ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Known as Endothelin 1 (human) ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Known as Endothelin 1 (pig) ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Known as Endothelin 1 (rana ridibunda) ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Known as Endothelin 1 (rat) ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Known as Endothelin-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00406731
3

NCT00745693

NCT05653973

NCT02906085

Known as ET-1 “Endothelin-1 (ET-1)” NCT00406731
Known as Human endothelin ChEMBL registry synonym — accepted as the source's own label CHEMBL437472
Modality Peptide Peptide Endothelin-1” NCT02906085
Route Intravenous “5 ng/kg/min intravenous infusion over 17 minutes” NCT00406731